Lamictal Tablet
Product Images NDC 0173-0642

Product Visual Gallery

This gallery contains 30 technical images submitted to the FDA as part of the official labeling for Lamictal (NDC 0173-0642). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaxosmithkline Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lamotrigine Chemical Structure (Lamictal Spl Graphic 01)

Chemical structure of lamotrigine, the active ingredient in LAMICTAL oral suspension tablets, as depicted in the image.*

FDA Label Image

Figure 1: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Mood Episode (trial 1) (Lamictal Spl Graphic 02)

A Kaplan-Meier failure probability curve comparing LAMICTAL (lamotrigine) and placebo over approximately 100 weeks. The vertical axis shows failure probability percentage, and the horizontal axis shows weeks. The graph includes censored data points and illustrates different failure rates between LAMICTAL and placebo groups over time.*

FDA Label Image

Figure 2: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Mood Episode (trial 2) (Lamictal Spl Graphic 03)

A Kaplan-Meier survival curve chart showing failure probability (%) over weeks for LAMICTAL and Placebo groups. The X-axis represents time in weeks up to 80, and the Y-axis shows failure probability from 0% to 100%. The chart includes censored data indicated by plus signs and compares the treatment effect of LAMICTAL versus Placebo.*

FDA Label Image

25 mg Tablet (Lamictal Spl Graphic 04)

LAMICTAL 25 mg/1 tablet for suspension oral medication packaging label from GlaxoSmithKline LLC. The front label displays the brand name LAMICTAL prominently, with the strength 25 mg per 1 tablet indicated, and specifies the form as a tablet for suspension. The label also includes usage instructions and safety warnings in smaller text.*

FDA Label Image

100 mg Tablet (Lamictal Spl Graphic 05)

LAMICTAL 15 mg tablet, an oral tablet for suspension, with the imprint 'LAMICTAL 15' on one side. This prescription drug is manufactured by GlaxoSmithKline LLC and contains the active ingredient lamotrigine in a 15 mg strength not listed among other strengths in the database entry.*

FDA Label Image

150 mg Tablet (Lamictal Spl Graphic 06)

LAMICTAL 15 mg tablet, a prescription oral tablet for suspension, is shown with a distinctive polygonal shape imprinted with 'LAMICTAL 15'. This image represents the GlaxoSmithKline LLC-labeled dosage form of lamotrigine.*

FDA Label Image

200 mg Tablet (Lamictal Spl Graphic 07)

The image shows a round tablet imprinted with "LAMICTAL 24G". This corresponds to LAMICTAL (lamotrigine) tablets, for oral suspension, manufactured by GlaxoSmithKline LLC. The imprint identifies the product and strength but does not specify the exact dose visible in this image.*

FDA Label Image

2 mg Cd Tablet (Lamictal Spl Graphic 08)

LAMICTAL 25 mg/1 tablet for suspension oral medication by GlaxoSmithKline LLC. The carton is white with purple and black text, featuring the brand name, generic name lamotrigine, strength of 25 mg per tablet for suspension, and the labeler GlaxoSmithKline LLC.*

FDA Label Image

5 mg Cd Tablet (Lamictal Spl Graphic 09)

LAMICTAL lamotrigine oral suspension tablets packaging label by GlaxoSmithKline LLC. The label indicates the tablet form of lamotrigine for suspension use, showing seven available strengths from 2 mg/1 to 200 mg/1. The brand name LAMICTAL is prominently displayed alongside the generic name.*

FDA Label Image

25 mg Cd Tablet (Lamictal Spl Graphic 10)

LAMICTAL tablets for suspension labeled with various strengths including 2 mg, 5 mg, 25 mg, 50 mg, 100 mg, 150 mg, and 200 mg, containing the active ingredient lamotrigine. The label identifies GlaxoSmithKline LLC as the labeler and specifies the oral route of administration.*

FDA Label Image

25 mg Odt (Lamictal Spl Graphic 11)

LAMICTAL 25 mg oral tablet imprint showing "LMT" inside a circle on one side and "25" inside a circle on the other side. Manufactured by GlaxoSmithKline LLC. The tablet is scored for suspension preparation.*

FDA Label Image

50 mg Odt (Lamictal Spl Graphic 12)

Lamitcal 50 mg oral tablet imprints shown. One side is marked with LMT inside a circle, and the other side displays 50 enclosed in a circle. The tablet is identifiable by these two-sided imprints. Labeler: GlaxoSmithKline LLC.*

FDA Label Image

100 mg Odt (Lamictal Spl Graphic 13)

LAMICTAL 100 mg tablet for suspension, oral use, showing round white tablet imprinted with "LAMICTAL" on one side and "100" on the other. Manufactured by GlaxoSmithKline LLC.*

FDA Label Image

200 mg Odt (Lamictal Spl Graphic 14)

The image shows two sides of round tablets. One side is embossed with "LAMICTAL" split in two lines, and the other side is embossed with the number "200", indicating a 200 mg dosage strength of Lamictal (lamotrigine) tablets for suspension, labeled by GlaxoSmithKline LLC.*

FDA Label Image

Lamictal 100mg 100 Count Label (Lamictal Spl Graphic 15)

Label for LAMICTAL (lamotrigine) tablets, 100 mg strength, in a box containing 100 tablets. The label specifies oral tablet form for suspension use, includes storage instructions, caution to verify the product dispensed, and a note to dispense the accompanying Medication Guide. Manufactured by GlaxoSmithKline LLC, made in India, with a visible NDC code 0173-0642-55.*

FDA Label Image

Lamctal 150 mg 60 Count Label (Lamictal Spl Graphic 16)

LAMICTAL (lamotrigine) 150 mg tablets packaging label shows a bottle containing 60 scored tablets. The label includes storage instructions, a caution to verify the product dispensed, and states the product is distributed by GlaxoSmithKline LLC. It also warns not to accept if the printed seal under the cap is missing or broken.*

FDA Label Image

Lamictal 200mg 60 Count Label (Lamictal Spl Graphic 17)

LAMICTAL (lamotrigine) 200 mg tablets label for oral use. The label includes the brand and generic names, strength (200 mg), dosage form (tablets), and packaging size (60 tablets). It contains cautions about verifying the product, storage instructions, and dispensing conditions. The label indicates distribution by GlaxoSmithKline LLC, manufactured in India, and includes a barcode and the note Rx only.*

FDA Label Image

Lamictal Starter Kit Blue 25mg Carton (Lamictal Spl Graphic 18)

LAMICTAL (lamotrigine) tablets starter kit label in blue color by GlaxoSmithKline LLC. It is for patients taking valproate and contains 35 tablets, each with 25 mg lamotrigine strength. Instructions provide a titration schedule for weeks 1 through 5, with dosage changes from every other day to twice daily. Label includes prescription only (Rx only) designation and warnings to verify dispensed product and to dispense an enclosed medication guide.*

FDA Label Image

Lamictal Starter Kit Green 25mg And 100mg Carton (Lamictal Spl Graphic 19)

LAMICTAL (lamotrigine) tablets packaging label for a Starter Kit by GlaxoSmithKline LLC. The label specifies use instructions for patients taking certain anticonvulsants but not valproate. It contains 84 tablets of 25 mg and 14 tablets of 100 mg lamotrigine with dosing guidance over five weeks. The label includes NDC 0173-0817-28 and the GSK logo.*

FDA Label Image

Lamictal Starter Kit Orange 25mg And 100mg Carton (Lamictal Spl Graphic 20)

Label for LAMICTAL (lamotrigine) tablets, a human prescription oral drug by GlaxoSmithKline LLC. This starter kit includes 42 tablets of 25 mg and 7 tablets of 100 mg strength. The label provides dosing instructions for weeks 1 to 5 and cautions to verify the product dispensed. It advises patients not taking certain anticonvulsants and recommends consulting a physician about maintenance dose.*

FDA Label Image

Lamictal Cd 2mg 30 Count Label (Lamictal Spl Graphic 21)

LAMICTAL 2 mg tablets for oral suspension label by GlaxoSmithKline LLC. The label states each tablet contains 2 mg lamotrigine, with 30 tablets per package. It includes storage instructions, a caution to verify dispensed product, a warning not to accept if the printed seal under the cap is missing or broken, and dispensing guidance. The label has the NDC code 0173-0699-00 and instructions to dispense the accompanying medication guide.*

FDA Label Image

Lamictal Cd 5mg 100 Count Label (Lamictal Spl Graphic 22)

LAMICTAL 5 mg tablets for oral suspension label from GlaxoSmithKline LLC. The label shows the proprietary name LAMICTAL with generic name lamotrigine, dosage strength 5 mg per tablet, and package containing 100 tablets. It includes directions indicating tablets may be swallowed whole, chewed, or dispersed in water or diluted fruit juice, storage instructions, and caution to verify the product dispensed. The label also shows the NDC number and identifies the product as Rx only.*

FDA Label Image

Lamictal Cd 25mg 100 Count Label (Lamictal Spl Graphic 23)

LAMICTAL 25 mg tablets for oral suspension label with lamotrigine as the active ingredient. The label shows a package containing 100 tablets. It includes usage instructions, storage conditions, and caution warnings. The labeler is GlaxoSmithKline LLC, and the product is made in India. The NDC number is 0173-0527-00.*

FDA Label Image

Lamictal Odt 25mg 30 Count Maintenance Pack Carton (Lamictal Spl Graphic 24)

LAMICTAL ODT (lamotrigine) Maintenance Pack oral disintegrating tablets, 25 mg strength, containing 30 tablets in the package. The label indicates it is intended for patients already taking LAMICTAL and not for initial titration. The labeler is GlaxoSmithKline LLC.*

FDA Label Image

W:\establishment Reg & Drug Listing\r5 Gsk Rx\lamictal\10000000146531 Lamictal Odt 50mg 30 Count Maintenance Pack Carton (Lamictal Spl Graphic 25)

LAMICTAL 50 mg Maintenance Pack orally disintegrating tablets (ODT) box label. The package contains 30 tablets of lamotrigine for oral use. The label includes a caution to verify the product dispensed and notes it is intended for patients already taking LAMICTAL, not for initial titration. The manufacturer is GlaxoSmithKline LLC.*

FDA Label Image

Lamictal Odt 100mg 30 Count Maintenance Pack Carton (Lamictal Spl Graphic 26)

LAMICTAL Maintenance Pack 100 mg orally disintegrating tablets (ODT) by GlaxoSmithKline LLC. The label indicates the package contains 30 tablets and is intended for patients already taking LAMICTAL, not for initial titration. The label also cautions to verify product dispensed and to provide the medication guide to each patient.*

FDA Label Image

Lamictal Odt 200 mg 30 Count Maintenance Pack Carton (Lamictal Spl Graphic 27)

LAMICTAL ODT Maintenance Pack 200 mg tablets packaging label. The label shows 30 orally disintegrating tablets (ODT) containing lamotrigine, manufactured by GlaxoSmithKline LLC. It includes a caution that the pack is intended only for patients already taking LAMICTAL and is not for initial titration, with a reminder to verify the product dispensed.*

FDA Label Image

Lamictal Odt Kit Blue 25mg And 50 mg Carton (Lamictal Spl Graphic 28)

LAMICTAL ODT (lamotrigine) Patient Titration Kit packaging label for orally disintegrating tablets by GlaxoSmithKline LLC. The label notes the kit contains 21 tablets of 25 mg strength and 7 tablets of 50 mg strength. Instructions for dosage over five weeks are outlined, specifying the number of tablets per day. The label includes a caution to verify the product dispensed and advises dispensing the accompanying Medication Guide to patients.*

FDA Label Image

Lamictal Odt Kit Green 50mg And 100mg Carton (Lamictal Spl Graphic 29)

LAMICTAL ODT (lamotrigine) Patient Titration Kit label from GlaxoSmithKline LLC. The kit contains 42 tablets of 50 mg and 14 tablets of 100 mg for oral disintegrating tablet form. The label includes dosage instructions for weeks 1 through 5, specifying the number of tablets per day and timing, with a caution to verify the product dispensed and to dispense the accompanying medication guide to patients.*

FDA Label Image

Lamictal Odt Kit Orange 25mg, 50 mg, 100mg Carton (Lamictal Spl Graphic 30)

LAMICTAL ODT (lamotrigine) orally disintegrating tablets patient titration kit label by GlaxoSmithKline LLC. This kit includes 25 mg, 50 mg, and 100 mg tablets with instructions for dosing over five weeks. The label highlights use for patients not taking certain listed drugs and includes a caution to verify the dispensed product and a reminder to dispense the medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.